Novartis
NVS
#57
Rank
A$320.56 B
Marketcap
$160.34
Share price
0.41%
Change (1 day)
8.05%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Earnings for Novartis (NVS)

Earnings in 2024 (TTM): A$18.92 Billion

According to Novartis's latest financial reports the company's current earnings are A$49.94 Billion. In 2023 the company made an earning of A$14.02 Billion, an increase over its 2022 earnings that were of A$12.36 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novartis from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$18.92 B34.89%
2023 A$14.02 B13.48%
2022 A$12.36 B-69.24%
2021 A$40.18 B164.6%
2020 A$15.18 B10.49%
2019 A$13.74 B-36.26%
2018 A$21.56 B55.86%
2017 A$13.83 B15.12%
2016 A$12.01 B-3.9%
2015 A$12.50 B-33.72%
2014 A$18.86 B14.87%
2013 A$16.42 B-2.93%
2012 A$16.92 B2.15%
2011 A$16.56 B-7.94%
2010 A$17.99 B17.94%
2009 A$15.25 B4.45%
2008 A$14.60 B27.5%
2007 A$11.45 B-6.31%
2006 A$12.22 B9.46%
2005 A$11.17 B5.17%
2004 A$10.62 B13.84%
2003 A$9.33 B-38.51%
2002 A$15.17 B574.04%
2001 A$2.25 B83%
2000 A$1.23 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$25.35 B 29.52%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$1.87 Billion-109.52%๐Ÿ‡บ๐Ÿ‡ธ USA
A$28.28 B 44.48%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.39 B-41.82%๐Ÿ‡ซ๐Ÿ‡ท France
A$6.41 B-67.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$1.27 B-93.50%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-A$10.58 Billion-154.04%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.42 B-46.76%๐Ÿ‡บ๐Ÿ‡ธ USA
A$14.45 B-26.15%๐Ÿ‡ฌ๐Ÿ‡ง UK